Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.52 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.52 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5493511 | 1.00 | KMT2A (0.53) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| SCHEMBL7043592 | 1.00 | KMT2A (0.53) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| Carglumic Acid SCHEMBL27983953 | 0.87 | FOLH1 (0.69) | FOLH1RIMKLANAALAD2CA2CA1 | |
| SCHEMBL28282404 | 0.87 | KMT2A (0.53) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| Carglumic Acid SCHEMBL27983952 | 0.87 | FOLH1 (0.69) | FOLH1RIMKLANAALAD2CA2CA1 | |
| SCHEMBL1719073 | 0.87 | KMT2A (0.53) | KMT2AFOLH1RIMKLANAALAD2CA2 | |
| Carglumic Acid SCHEMBL910483 | 0.87 | FOLH1 (0.69) | FOLH1RIMKLANAALAD2CA2CA1 | |
| Carglumic Acid SCHEMBL910527 | 0.87 | FOLH1 (0.69) | FOLH1RIMKLANAALAD2CA2CA1 | |
| Carglumic Acid SCHEMBL373546 | 0.87 | FOLH1 (0.69) | FOLH1RIMKLANAALAD2CA2CA1 | |
| SCHEMBL7047615 | 0.85 | GNPAT (0.56) | KMT2AFOLH1RIMKLANAALAD2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101565385-B | Pigling intestinal tract nutrition regulation and control substance N-carbamoylglutamine and preparation method | INST SUBTROPICAL AGRI CAS | 2014-03-12 | — | — | CN | claimed |
| CN-101565385-A | Pigling intestinal tract nutrition regulation and control substance N-carbamoylglutamine and preparation method | INST SUBTROPICAL AGRICULTUR (CN) | 2009-10-28 | — | — | CN | claimed |
| EP-0815833-B1 | Malodour preventing agents | GIVAUDAN SA (CH) | 2003-04-09 | — | — | EP | claimed |
| EP-1209234-A1 | STEREOSTRUCTURE OF DECARBAMYLASE AND METHOD OF USING THE SAME | Kaneka Corporation (JP) | 2002-05-29 | — | — | EP | claimed |
| US-5925339-A | ODORLESS DEODORANTS AND ANTIPERSPIRANTS | GIVAUDAN ROURE SA (CH) | 1999-07-20 | — | — | US | claimed |
| EP-0815833-A2 | Malodour preventing agents | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-01-07 | — | — | EP | claimed |
| US-20230390297-A1 | USE OF NUCLEOTIDE SYNTHESIS INHIBITORS FOR TARGETED THERAPY IN MLL3/4 COMPASS MUTANT CANCER | NORTHWESTERN UNIVERSITY | 2023-12-07 | — | — | US | disclosed |
| CN-114450293-A | Anthracycline derivatives | 阿尔麦克探索有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-106729746-B | To the preparation method and applications of the tumor infiltrating nanosystems of the partial size shrinkage type of FAP- α enzyme, reducing environment sensitive | 郑州大学 | 2019-11-22 | — | — | CN | disclosed |
| CN-105085678-B | The antibody of angiopoietin-2 and its application | 阿斯利康公司 | 2019-05-07 | — | — | CN | disclosed |
| CN-109180802-A | Compound, composition with hypoglycemic effect and application thereof | 爱德迪安（北京）生物技术有限公司 | 2019-01-11 | — | — | CN | disclosed |
| WO-2018170234-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-09-20 | — | — | WO | disclosed |
| CN-108513576-A | Tunable variant immunoglobulin superfamily domains and engineered cell therapies | 高山免疫科学股份有限公司 | 2018-09-07 | — | — | CN | disclosed |
| EP-1616945-A1 | Process for producing D-N-carbamoyl-alpha-amino acids | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-01-18 | — | — | EP | disclosed |
| EP-0815833-B1 | Malodour preventing agents | GIVAUDAN SA (CH) | 2003-04-09 | — | — | EP | disclosed |
| EP-1209234-A1 | STEREOSTRUCTURE OF DECARBAMYLASE AND METHOD OF USING THE SAME | Kaneka Corporation (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-6150542-A | COSMETICS; IN DEODORIZERS, ANTIPERSPIRANTS | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2000-11-21 | — | — | US | disclosed |
| US-5925339-A | ODORLESS DEODORANTS AND ANTIPERSPIRANTS | GIVAUDAN ROURE SA (CH) | 1999-07-20 | — | — | US | disclosed |
| EP-0815833-A2 | Malodour preventing agents | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-01-07 | — | — | EP | disclosed |
| EP-0801131-A1 | PROCESS FOR PRODUCING D-N-CARBAMOYL-$g(a)-AMINO ACID | Kanegafuchi Chemical Industry Co., Ltd. (JP) | 1997-10-15 | — | — | EP | disclosed |